Overall, we suggest a model in which circPTPN12/hnRNPM complex interacts with IL-6 pre-mRNA and improves its stability, then further activates the STAT3 pathway and promotes the progression and sunitinib resistance of RCC (Fig. 8f). The gene discussed is HNRNPM; the disease is renal cell carcinoma.